-+ 0.00%
-+ 0.00%
-+ 0.00%

Exicure Plans to Acquire 20%-100% Stake in NeuroQ Through Share Swap

PUBT·11/20/2026 18:00:45
Listen to the news
Exicure Plans to Acquire 20%-100% Stake in NeuroQ Through Share Swap
  • Exicure entered an agreement on Nov. 19, 2026, to acquire a 20%-100% stake in NeuroQ Biologics.
  • The proposed acquisition would primarily exchange Exicure common shares for NeuroQ shares held by Laonz.
  • The final stake and share exchange ratio remain subject to subsequent agreements, applicable approvals and Nasdaq requirements.
  • Following completion, planned development funding of up to US$500,000 would support X-CUE, subject to approvals, funding availability and definitive arrangements.
  • NeuroQ will lead commercialization of X-CUE, augmented-reality smart glasses designed to help Parkinson’s patients manage freezing of gait.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611201300PRIMZONEFULLFEED9882246) on November 20, 2026, and is solely responsible for the information contained therein.